Renal events in patients receiving neprilysin inhibitors: a systematic review and meta-analysis.

Clara Vollmer Barbosa,Hannah Lang,Anette Melk,Bernhard M W Schmidt

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association（2022）

引用 5|浏览0

暂无评分

摘要

NEPi + ACEi/ARBs are safe in terms of renal adverse events. Longer trials focusing on CKD are needed to evaluate the effect of NEPi on decreasing progression of CKD.

查看译文

关键词

neprilysin inhibitor,renal events,sacubitril

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要